Showing results (781-790 of 1,182) with videos related to

Sort By:
Pageof 119
Applied Health Economics and Health Policy|November 29, 2021
Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven CountriesLaurence S J Roope, Adrian Barnett, Paolo Candio, et al.
Applied Health Economics and Health Policy|December 21, 2021
A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North AfricaMouaddh Abdulmalik Nagi, Pramitha Esha Nirmala Dewi, Montarat Thavorncharoensap, et al.
Applied Health Economics and Health Policy|December 29, 2021
Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies GuidanceRuth Louise Poole, Megan Dale, Helen Morgan, et al.
Applied Health Economics and Health Policy|December 29, 2021
Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four CountriesLaura Vallejo-Torres, Borja García-Lorenzo, Laura Catherine Edney, et al.
Applied Health Economics and Health Policy|October 26, 2022
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from LebanonJalal Dahham, Ingrid Kremer, Mickaël Hiligsmann, et al.
Applied Health Economics and Health Policy|October 19, 2022
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for IndiaYashika Chugh, Pankaj Bahuguna, Aamir Sohail, et al.
Applied Health Economics and Health Policy|September 22, 2022
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee OsteoarthritisKangho Suh, Brian J Cole, Andreas Gomoll, et al.
Applied Health Economics and Health Policy|September 22, 2022
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy PerspectivePankaj Bahuguna, Emiko Masaki, Gursimer Jeet, et al.
Applied Health Economics and Health Policy|October 31, 2022
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes PatientsAnna-Katharina Böhm, Udo Schneider, Tom Stargardt
Applied Health Economics and Health Policy|August 30, 2022
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research StudyZe Cong, Oth Tran, James Nelson, et al.
Pageof 119